Medicus Sciences Acquisition Corp. Warrant
MSACW
MSACW was delisted on the 17th of February, 2023.
16 hedge funds and large institutions have $305K invested in Medicus Sciences Acquisition Corp. Warrant in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% less capital invested
Capital invested by funds: $306K → $305K (-$856)
6% less funds holding
Funds holding: 17 → 16 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MC
Meteora Capital
Boca Raton,
Florida
|
+$359 |
Top Sellers
MSACW Hedge Fund Activity: Q4 2022 in Review
16 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Medicus Sciences Acquisition Corp. Warrant (MSACW) for Q4 2022, worth a combined $305K — down 0.28% from $306K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of MSACW and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was Meteora Capital, adding an estimated $359.
- 16 institutional investors held Medicus Sciences Acquisition Corp. Warrant (MSACW) as of Q4 2022, down from 17 in Q3 2022.
- Funds reported $305K of Medicus Sciences Acquisition Corp. Warrant stock for Q4 2022, down 0.28% quarter-over-quarter.
- 1 fund opened new Medicus Sciences Acquisition Corp. Warrant positions in Q4 2022 and 2 closed out, a net change of -1 holder.
- The largest Medicus Sciences Acquisition Corp. Warrant buyer in Q4 2022 was Meteora Capital, an estimated $359 added.
Based on aggregated 13F filings for Q4 2022.